Aviron Message Board - Msg: 1881221

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.060

-12.3%

12:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nelli who wrote (73)	7/31/1997 9:29:00 PM
From: Brad C. Dunlap	of 645

Hi Wu, your point is well taken and I believe your experience is more valid then mine on this issue. Now, how expensive are those lollipops? The fact that we're talking about a few squirts as opposed to a shot, due you see any reduction in labor whatsoever? I wonder what the difference in material costs might be since AVIR eliminates the cheap syringe but probably more expensive in packaging that contains the nasal spray. Appears to be immaterial and probably a wash. I'm curious in your opinion on nasal delivery as opposed to a shot as this in my mind appears to be one of the key factors. What type of premium could possibly be passed on to the consumer for the advantage of nasal delivery verse shot? Better yet, nasal delivery with superior efficacy. I realize that you are short AVIR and respect your reasons in being short as I can follow your mind set in arriving at your decision. Any thoughts are appreciated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next